Men can get HIV through unprotected anal or vaginal sex with an infected partner, through sharing needles or injection equipment, and less commonly through occupational needlestick injuries or other blood exposures. Sexual contact is by far the most common route, but the level of risk varies dramatically depending on the type of sex, whether a condom is used, and whether either partner is on HIV medication.
Sexual Transmission: Which Acts Carry the Most Risk
Not all sexual exposure carries equal risk. The CDC estimates per-act transmission probabilities assuming no condoms, no PrEP, and no antiretroviral treatment for the HIV-positive partner. The numbers per 10,000 exposures break down like this:
- Receptive anal sex (bottoming): about 138 per 10,000 acts, or roughly 1 in 72
- Insertive anal sex (topping): about 11 per 10,000 acts, or roughly 1 in 909
- Insertive vaginal sex: lower still, in the range of 4 per 10,000 acts
Receptive anal sex is the highest-risk sexual activity for HIV acquisition regardless of gender. The lining of the rectum is thin, has a rich blood supply, and tears easily during intercourse, giving the virus direct access to immune cells beneath the surface. By contrast, during insertive sex (topping or vaginal penetration), the virus has to cross the tougher skin of the penis, which is a less efficient route.
These are averages. A single encounter can transmit HIV, or someone could have dozens of exposures without infection. The per-act numbers are useful for understanding relative risk, not for predicting any individual event.
How HIV Actually Enters Through the Penis
During sex, the virus crosses the mucosal surfaces of the penis. The inner foreskin is particularly vulnerable because it has a thinner protective layer and a higher concentration of the immune cells that HIV targets. Retraction of the foreskin during intercourse exposes this lightly protected tissue to vaginal or rectal secretions, and any microtears multiply the risk.
Circumcision removes this vulnerable tissue, leaving the urethral opening as the only unprotected mucosal surface on the penis. That’s a much smaller area for the virus to exploit. Three large clinical trials in sub-Saharan Africa found that circumcision reduced the risk of female-to-male HIV transmission by approximately 60%, which led the World Health Organization to endorse voluntary medical male circumcision as a prevention strategy in 2007. Circumcision reduces risk but does not eliminate it.
Sharing Needles and Other Non-Sexual Routes
Sharing syringes or injection equipment with someone who has HIV is one of the most efficient ways the virus spreads. The estimated probability of infection from a single injection with a contaminated syringe is about 0.67%, or roughly 1 in 150. That’s considerably higher than the per-act risk of most sexual exposures because the virus is delivered directly into the bloodstream.
Other non-sexual routes include occupational needlestick injuries in healthcare settings (rare, with a per-event risk around 0.23%) and, very rarely, exposure to infected blood through open wounds. Transmission through tattoos, piercings, or barber tools is theoretically possible but extremely uncommon in settings with standard hygiene practices.
Factors That Raise or Lower Your Risk
Several things can shift the odds significantly in either direction.
Having another sexually transmitted infection makes HIV transmission easier. STIs like herpes, syphilis, or gonorrhea can cause sores, inflammation, or small breaks in the skin and mucosal lining. These create direct entry points for HIV and also draw more of the immune cells that HIV targets to the genital area. Getting tested and treated for STIs is a practical way to lower your HIV risk.
A higher viral load in the HIV-positive partner means more virus in blood, semen, and rectal fluids, which directly increases the chance of transmission during any exposure. Acute infection, the first few weeks after someone contracts HIV, produces an especially high viral load and is one of the most infectious periods. Many people don’t know they have HIV during this stage.
On the protective side, condoms reduce HIV transmission risk by roughly 90% or more when used consistently and correctly. PrEP, a daily pill taken by HIV-negative people, provides powerful additional protection. A study of men who have sex with men found that PrEP use was associated with a 79% reduction in HIV incidence in a real-world population, and clinical trials have shown even higher efficacy with consistent daily use.
When a Partner Is on Treatment
One of the most important findings in HIV science is that effective treatment eliminates sexual transmission. When someone living with HIV takes their medication as prescribed and achieves an undetectable viral load (fewer than 200 copies of the virus per milliliter of blood), they will not transmit HIV to sexual partners. This principle, known as U=U (undetectable equals untransmittable), is backed by studies involving thousands of couples over tens of thousands of sex acts with zero transmissions from the partner with an undetectable viral load.
This applies to both anal and vaginal sex. It does not, however, apply with the same certainty to sharing injection equipment. Scientists believe suppressed viral load likely reduces that risk too, but there isn’t enough data to confirm it prevents transmission through needles entirely.
Early Signs After Infection
If HIV is contracted, the first stage is called acute infection. It typically develops within 2 to 4 weeks. Some men experience flu-like symptoms: fever, headache, rash, sore throat, swollen lymph nodes, and muscle aches. These symptoms are easy to dismiss as a cold or flu and usually resolve on their own within a week or two. Many people have no noticeable symptoms at all. The absence of symptoms does not mean the virus isn’t present or that the person isn’t highly infectious.
Testing Windows and When to Get Checked
If you think you’ve been exposed, the type of HIV test determines how soon it can detect infection. No test can pick up HIV immediately after exposure.
- Nucleic acid tests (NAT): detect the virus itself and can identify infection 10 to 33 days after exposure
- Antigen/antibody lab tests (blood draw from a vein): reliable 18 to 45 days after exposure
- Rapid antigen/antibody tests (finger stick): 18 to 90 days after exposure
- Antibody-only tests (including most home tests): 23 to 90 days after exposure
A negative result within the first few weeks doesn’t rule out infection. If the initial test is negative but the exposure was recent, retesting after the window period closes gives a definitive answer. For a standard lab-based antigen/antibody test, a negative result at 45 days is highly reliable.